About
Immunocodex develops tolerogenic mRNA vaccines that reprogram immune cells to restore immune balance and treat autoimmune diseases by integrating tolerance-inducing signals with disease-specific autoantigens.
Explore Immunocodex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.